La bourse est fermée
  • CAC 40

    5 598,18
    +31,39 (+0,56 %)
     
  • Euro Stoxx 50

    3 527,79
    +16,85 (+0,48 %)
     
  • Dow Jones

    29 910,37
    +37,90 (+0,13 %)
     
  • EUR/USD

    1,1970
    +0,0057 (+0,48 %)
     
  • Gold future

    1 788,10
    -23,10 (-1,28 %)
     
  • BTC-EUR

    15 147,14
    +295,57 (+1,99 %)
     
  • CMC Crypto 200

    333,27
    -4,23 (-1,25 %)
     
  • Pétrole WTI

    45,53
    -0,18 (-0,39 %)
     
  • DAX

    13 335,68
    +49,11 (+0,37 %)
     
  • FTSE 100

    6 367,58
    +4,65 (+0,07 %)
     
  • Nasdaq

    12 205,85
    +111,44 (+0,92 %)
     
  • S&P 500

    3 638,35
    +8,70 (+0,24 %)
     
  • Nikkei 225

    26 644,71
    +107,40 (+0,40 %)
     
  • HANG SENG

    26 894,68
    +75,23 (+0,28 %)
     
  • GBP/USD

    1,3314
    -0,0042 (-0,32 %)
     

Global Biopharmaceutical Bioseparation Systems Industry

ReportLinker
·15 min de lecture

Global Biopharmaceutical Bioseparation Systems Market to Reach $12. 6 Billion by 2027. Amid the COVID-19 crisis, the global market for Biopharmaceutical Bioseparation Systems estimated at US$7.

New York, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Biopharmaceutical Bioseparation Systems Industry" - https://www.reportlinker.com/p03646060/?utm_source=GNW
1 Billion in the year 2020, is projected to reach a revised size of US$12.6 Billion by 2027, growing at aCAGR of 8.4% over the period 2020-2027. Chromatography, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$6.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Technologies segment is readjusted to a revised 8.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 12.6% CAGR

The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 12.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 7.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.We bring years of research experience to this 16th edition of our report. The 193-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • 3M Purification Inc.

  • Agilent Technologies, Inc.

  • Alfa Wassermann Separation Technologies LLC

  • Flottweg Separation Technology

  • GE Healthcare Life Sciences

  • GEA Westfalia Separator Group GmbH

  • KNAUER Wissenschaftliche Geräte GmbH

  • Konik Nanobiotech SL

  • Merck KGaA

  • Pall Corporation

  • ProMetic Life Sciences Inc.

  • Repligen Corp.

  • Sartorius Stedim Biotech

  • Thermo Fischer Scientific Inc.

  • Tosoh Bioscience Inc.

  • YMC Europe GMBH




Read the full report: https://www.reportlinker.com/p03646060/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Bioseparation Systems - Invaluable Tools in Biopharmaceutical
Manufacturing
Recent Market Activity
US Remains Market Leader; Developing Countries to Drive Market
Growth
Chromatography Leads the Pack
Global Market for Gas Chromatography Systems
Competitive Landscape
A Peek into Biopharmaceutical Manufacturing
Downstream Processing of Biosynthetic Products - An Overview
Growing Biopharmaceutical Market Drives Demand for
Bioseparation Systems
New Biologic License Application (BLA) Approvals-2017
New Biologic License Application (BLA) Approvals: 2016
New Biologic License Application (BLA) Approval: 2015
Biopharmaceutical Industry Transforms Downstream Processing
Growing Biological Drug Manufacturing Capacity to Drive Growth
Growing Market for Monoclonal Antibodies - A Key Review of
Current Status and Future Prospects
Approved Monoclonal Antibodies: 2014-2017
An Insight into Bioseparation of mAbs
Growing Biosimilars Market - A Clear Advantage for
Bioseparation Technologies
Patent Expiries of Major Biopharmaceutical Drugs in the US and
Europe
US APPROVED BIOSIMILARS AS OF DECEMBER 2017
EUROPE APPROVED BIOSIMILARS AS OF DECEMBER 2017
R&D Funding Crucial for Biologics and Bioseparation Market
Huge Biopharmaceutical Pipeline - A Clear Indicator of Future
Prospects
Global Competitor Market Shares
Biopharmaceutical Bioseparation Systems Competitor Market Share
Scenario Worldwide (in %): 2018 & 2029
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
3M Company (USA)
3M Purification, Inc. (USA)
Agilent Technologies, Inc. (USA)
Alfa Wassermann Separation Technologies, LLC (USA)
Flottweg Separation Technology (USA)
GEA Westfalia Separator Group GmbH (Germany)
GE Healthcare Life Sciences (USA)
KNAUER Wissenschaftliche Geräte GmbH (Germany)
Konik Nanobiotech SL (Spain)
Merck KGaA (Germany)
Pall Corporation (USA)
ProMetic Life Sciences, Inc. (Canada)
Sartorius Stedim Biotech (France)
Repligen Corporation (USA)
Thermo Fisher Scientific, Inc. (USA)
Tosoh Bioscience, Inc. (Japan)
YMC Europe GmbH (Germany)

3. MARKET TRENDS & DRIVERS
Increasing Need for Further Advances in Downstream Processing
Techniques
Process Optimization and Cost Reduction - Key Goals of
Innovations in Bioseparation
Continuous Bioseparation Gains Momentum
Process Intensification
Single-Use Systems Play a Key Role
Minimizing Centrifugation Steps
Integration of Down-Stream and Up-Stream
Developmental Efforts
Focus on Enhancing Capture Increases
Introduction of Diversified Resins on the Rise
Multicolumn System Lower Buffer and Resin Requirement
Single-Use Disposable Technologies Gain Attention
Select Commercial Disposable/Single-Use Technologies by Process
Technique
Innovations in Single-use Systems
Increasing Biopharma Productivity and Efficiency via Continuous
Manufacturing
Changing Paradigm of Primary Recovery in Bioseparation
Growing Use of Membrane Filtration in Biopharmaceutical
Manufacturing
Chromatography - The Gold Standard Purification Technology
Continuous Chromatography - A Key Technology for the Biopharma
Sector
Challenges to Separate Active Pharmaceutical Ingredients,
Chromatography to the Rescue
Inherent Benefits of Membrane Chromatography to Drive its Use
in Bioprocessing
SMBC - An Old Approach Gaining Significant Attention
Superior Efficiency Drives Use of Synthetic Ligands in Affinity
Chromatography
A Comparison of Protein and Synthetic Ligands
Increasing Alternatives to Protein A Column based Capturing
Twin-Column SMB - An Emerging Alternative to Protein A Columns
Chiral Chromatography Increases in Popularity
Flexible and Selective Chromatography Improves
Biopharmaceutical Efficiencies
Chromatography Efficiency and Selectivity
Mixed-Mode Chromatography
Multimode Chromatography
Mixed-Mode and Multimode Media Offer Cost Savings
Awareness of Mixed Mode and Multimode Media Operating Modes
Critical
Magnetic Separation as an Alternative to Chromatography - A Review
Reversible Precipitation - A Novel Bioseparation Technology

4. GLOBAL MARKET PERSPECTIVE
Table 1: Biopharmaceutical Bioseparation Systems Global Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 2: Biopharmaceutical Bioseparation Systems Global
Retrospective Market Scenario in US$ Million by Region/Country:
2012-2019

Table 3: Biopharmaceutical Bioseparation Systems Market Share
Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Chromatography (Technology) World Market by
Region/Country in US$ Million: 2020 to 2027

Table 5: Chromatography (Technology) Historic Market Analysis
by Region/Country in US$ Million: 2012 to 2019

Table 6: Chromatography (Technology) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Other Technologies (Technology) Potential Growth
Markets Worldwide in US$ Million: 2020 to 2027

Table 8: Other Technologies (Technology) Historic Market
Perspective by Region/Country in US$ Million: 2012 to 2019

Table 9: Other Technologies (Technology) Market Sales Breakdown
by Region/Country in Percentage: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Biopharmaceutical Bioseparation Systems Market Share (in %)
by Company: 2018 & 2025
Market Analytics
Table 10: Biopharmaceutical Bioseparation Systems Market in US$
Million in the United States by Technology: 2020-2027

Table 11: United States Biopharmaceutical Bioseparation Systems
Market Retrospective Analysis in US$ Million by Technology:
2012-2019

Table 12: United States Biopharmaceutical Bioseparation Systems
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

CANADA
Table 13: Biopharmaceutical Bioseparation Systems Market
Analysis in Canada in US$ Million by Technology: 2020-2027

Table 14: Biopharmaceutical Bioseparation Systems Market in
Canada: Historic Review in US$ Million by Technology for the
Period 2012-2019

Table 15: Canadian Biopharmaceutical Bioseparation Systems
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

JAPAN
Table 16: Japanese Medium & Long-Term Outlook for
Biopharmaceutical Bioseparation Systems Market in US$ Million
by Technology: 2020-2027

Table 17: Biopharmaceutical Bioseparation Systems Market in
Japan in US$ Million by Technology: 2012-2019

Table 18: Japanese Biopharmaceutical Bioseparation Systems
Market Percentage Share Distribution by Technology: 2012 VS
2020 VS 2027

CHINA
Table 19: Biopharmaceutical Bioseparation Systems Market
Estimates and Forecasts in China in US$ Million by Technology:
2020-2027

Table 20: Chinese Biopharmaceutical Bioseparation Systems
Retrospective Market Scenario in US$ Million by Technology:
2012-2019

Table 21: Biopharmaceutical Bioseparation Systems Market in
China: Percentage Share Analysis by Technology for 2012, 2020,
and 2027

EUROPE
Market Facts & Figures
European Biopharmaceutical Bioseparation Systems Market:
Competitor Market Share Scenario (in %) for 2018 & 2025
Market Analytics
Table 22: European Biopharmaceutical Bioseparation Systems
Market Demand Scenario in US$ Million by Region/Country:
2020-2027

Table 23: Biopharmaceutical Bioseparation Systems Market in
Europe: A Historic Market Perspective in US$ Million by
Region/Country for the Period 2012-2019

Table 24: European Biopharmaceutical Bioseparation Systems
Market Share Shift by Region/Country: 2012 VS 2020 VS 2027

Table 25: European Biopharmaceutical Bioseparation Systems
Market Assessment in US$ Million by Technology: 2020-2027

Table 26: European Biopharmaceutical Bioseparation Systems
Historic Market Review in US$ Million by Technology: 2012-2019

Table 27: Biopharmaceutical Bioseparation Systems Market in
Europe: Percentage Breakdown of Salesby Technology for 2012,
2020, and 2027

FRANCE
Table 28: French Biopharmaceutical Bioseparation Systems Market
Estimates and Projections in US$ Million by Technology:
2020-2027

Table 29: French Biopharmaceutical Bioseparation Systems
Historic Market Analysis in US$ Million by Technology:
2012-2019

Table 30: French Biopharmaceutical Bioseparation Systems Market
Share Breakdown by Technology: 2012 VS 2020 VS 2027

GERMANY
Table 31: German Biopharmaceutical Bioseparation Systems Latent
Demand Forecasts in US$ Million by Technology: 2020-2027

Table 32: Biopharmaceutical Bioseparation Systems Market in
Germany: A Historic Perspective by Technology in US$ Million
for the Period 2012-2019

Table 33: German Biopharmaceutical Bioseparation Systems Market
Share Breakdown by Technology: 2012 VS 2020 VS 2027

ITALY
Table 34: Biopharmaceutical Bioseparation Systems Market
Estimates and Forecasts in Italy in US$ Million by Technology:
2020-2027

Table 35: Italian Biopharmaceutical Bioseparation Systems
Retrospective Market Scenario in US$ Million by Technology:
2012-2019

Table 36: Biopharmaceutical Bioseparation Systems Market in
Italy: Percentage Share Analysis by Technology for 2012, 2020,
and 2027

UNITED KINGDOM
Table 37: United Kingdom Medium & Long-Term Outlook for
Biopharmaceutical Bioseparation Systems Market in US$ Million
by Technology: 2020-2027

Table 38: Biopharmaceutical Bioseparation Systems Market in the
United Kingdom in US$ Million by Technology: 2012-2019

Table 39: United Kingdom Biopharmaceutical Bioseparation
Systems Market Percentage Share Distribution by Technology:
2012 VS 2020 VS 2027

SPAIN
Table 40: Biopharmaceutical Bioseparation Systems Market
Analysis in Spain in US$ Million by Technology: 2020-2027

Table 41: Biopharmaceutical Bioseparation Systems Market in
Spain: Historic Review in US$ Million by Technology for the
Period 2012-2019

Table 42: Spanish Biopharmaceutical Bioseparation Systems
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

RUSSIA
Table 43: Biopharmaceutical Bioseparation Systems Market in US$
Million in Russia by Technology: 2020-2027

Table 44: Russian Biopharmaceutical Bioseparation Systems
Market Retrospective Analysis in US$ Million by Technology:
2012-2019

Table 45: Russian Biopharmaceutical Bioseparation Systems
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 46: Rest of Europe Biopharmaceutical Bioseparation
Systems Market Assessment in US$ Million by Technology:
2020-2027

Table 47: Rest of Europe Biopharmaceutical Bioseparation
Systems Historic Market Review in US$ Million by Technology:
2012-2019

Table 48: Biopharmaceutical Bioseparation Systems Market in
Rest of Europe: Percentage Breakdown of Sales by Technology for
2012, 2020, and 2027

ASIA-PACIFIC
Table 49: Asia-Pacific Biopharmaceutical Bioseparation Systems
Market Estimates and Forecasts in US$ Million by
Region/Country: 2020-2027

Table 50: Biopharmaceutical Bioseparation Systems Market in
Asia-Pacific: Historic Market Analysis in US$ Million by
Region/Country for the Period 2012-2019

Table 51: Asia-Pacific Biopharmaceutical Bioseparation Systems
Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 52: Asia-Pacific Biopharmaceutical Bioseparation Systems
Market Estimates and Projections in US$ Million by Technology:
2020-2027

Table 53: Asia-Pacific Biopharmaceutical Bioseparation Systems
Historic Market Analysis in US$ Million by Technology:
2012-2019

Table 54: Asia-Pacific Biopharmaceutical Bioseparation Systems
Historic Market Analysis in US$ Million by Technology: 2012 VS
2020 VS 2027

AUSTRALIA
Table 55: Australian Biopharmaceutical Bioseparation Systems
Latent Demand Forecasts in US$ Million by Technology: 2020-2027

Table 56: Biopharmaceutical Bioseparation Systems Market in
Australia: A Historic Perspective by Technology in US$ Million
for the Period 2012-2019

Table 57: Australian Biopharmaceutical Bioseparation Systems
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

INDIA
Table 58: Biopharmaceutical Bioseparation Systems Market
Analysis in India in US$ Million by Technology: 2020-2027

Table 59: Biopharmaceutical Bioseparation Systems Market in
India: Historic Review in US$ Million by Technology for the
Period 2012-2019

Table 60: Indian Biopharmaceutical Bioseparation Systems Market
Share Breakdown by Technology: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 61: Biopharmaceutical Bioseparation Systems Market in
South Korea: Recent Past, Current and Future Analysis in US$
Million by Technology for the Period 2020-2027

Table 62: South Korean Biopharmaceutical Bioseparation Systems
Historic Market Analysis in US$ Million by Technology:
2012-2019

Table 63: Biopharmaceutical Bioseparation Systems Market Share
Distribution in South Korea by Technology: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 64: Rest of Asia-Pacific Medium & Long-Term Outlook for
Biopharmaceutical Bioseparation Systems Market in US$ Million
by Technology: 2020-2027

Table 65: Biopharmaceutical Bioseparation Systems Market in
Rest of Asia-Pacific in US$ Million by Technology: 2012-2019

Table 66: Rest of Asia-Pacific Biopharmaceutical Bioseparation
Systems Market Percentage Share Distribution by Technology:
2012 VS 2020 VS 2027

LATIN AMERICA
Table 67: Latin American Biopharmaceutical Bioseparation
Systems Market Trends by Region/Country in US$ Million:
2020-2027

Table 68: Biopharmaceutical Bioseparation Systems Market in
Latin America in US$ Million by Region/Country: A Historic
Perspective for the Period 2012-2019

Table 69: Latin American Biopharmaceutical Bioseparation
Systems Market Percentage Breakdown of Sales by Region/Country:
2012, 2020, and 2027

Table 70: Biopharmaceutical Bioseparation Systems Market
Estimates and Forecasts in Latin America in US$ Million by
Technology: 2020-2027

Table 71: Latin American Biopharmaceutical Bioseparation
Systems Retrospective Market Scenario in US$ Million by
Technology: 2012-2019

Table 72: Biopharmaceutical Bioseparation Systems Market in
Latin America : Percentage Analysisby Technology for 2012,
2020, and 2027

ARGENTINA
Table 73: Argentinean Biopharmaceutical Bioseparation Systems
Market Assessment in US$ Million by Technology: 2020-2027

Table 74: Argentinean Biopharmaceutical Bioseparation Systems
Historic Market Review in US$ Million by Technology: 2012-2019

Table 75: Biopharmaceutical Bioseparation Systems Market in
Argentina: Percentage Breakdown of Sales by Technology for
2012, 2020, and 2027

BRAZIL
Table 76: Brazilian Biopharmaceutical Bioseparation Systems
Market Estimates and Projections in US$ Million by Technology:
2020-2027

Table 77: Brazilian Biopharmaceutical Bioseparation Systems
Historic Market Analysis in US$ Million by Technology:
2012-2019

Table 78: Brazilian Biopharmaceutical Bioseparation Systems
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

MEXICO
Table 79: Mexican Biopharmaceutical Bioseparation Systems
Latent Demand Forecasts in US$ Million by Technology: 2020-2027

Table 80: Biopharmaceutical Bioseparation Systems Market in
Mexico: A Historic Perspective by Technology in US$ Million for
the Period 2012-2019

Table 81: Mexican Biopharmaceutical Bioseparation Systems
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 82: Biopharmaceutical Bioseparation Systems Market in US$
Million in Rest of Latin America by Technology: 2020-2027

Table 83: Rest of Latin America Biopharmaceutical Bioseparation
Systems Market Retrospective Analysis in US$ Million by
Technology: 2012-2019

Table 84: Rest of Latin America Biopharmaceutical Bioseparation
Systems Market Share Breakdown by Technology: 2012 VS 2020 VS
2027

MIDDLE EAST
Table 85: The Middle East Biopharmaceutical Bioseparation
Systems Market Estimates and Forecasts in US$ Million by
Region/Country: 2020-2027

Table 86: Biopharmaceutical Bioseparation Systems Market in the
Middle East by Region/Country in US$ Million: 2012-2019

Table 87: The Middle East Biopharmaceutical Bioseparation
Systems Market Share Breakdown by Region/Country: 2012, 2020,
and 2027

Table 88: The Middle East Biopharmaceutical Bioseparation
Systems Market Analysis in US$ Million by Technology: 2020-2027

Table 89: Biopharmaceutical Bioseparation Systems Market in the
Middle East: Historic Review in US$ Million by Technology for
the Period 2012-2019

Table 90: The Middle East Biopharmaceutical Bioseparation
Systems Market Share Breakdown by Technology: 2012 VS 2020 VS
2027

IRAN
Table 91: Iranian Medium & Long-Term Outlook for
Biopharmaceutical Bioseparation Systems Market in US$ Million
by Technology: 2020-2027

Table 92: Biopharmaceutical Bioseparation Systems Market in
Iran in US$ Million by Technology: 2012-2019

Table 93: Iranian Biopharmaceutical Bioseparation Systems
Market Percentage Share Distribution by Technology: 2012 VS
2020 VS 2027

ISRAEL
Table 94: Israeli Biopharmaceutical Bioseparation Systems
Market Assessment in US$ Million by Technology: 2020-2027

Table 95: Israeli Biopharmaceutical Bioseparation Systems
Historic Market Review in US$ Million by Technology: 2012-2019

Table 96: Biopharmaceutical Bioseparation Systems Market in
Israel: Percentage Breakdown of Sales by Technology for 2012,
2020, and 2027

SAUDI ARABIA
Table 97: Biopharmaceutical Bioseparation Systems Market
Estimates and Forecasts in Saudi Arabia in US$ Million by
Technology: 2020-2027

Table 98: Saudi Arabian Biopharmaceutical Bioseparation Systems
Retrospective Market Scenario in US$ Million by Technology:
2012-2019

Table 99: Biopharmaceutical Bioseparation Systems Market in
Saudi Arabia: Percentage Share Analysis by Technology for 2012,
2020, and 2027

UNITED ARAB EMIRATES
Table 100: Biopharmaceutical Bioseparation Systems Market in
the United Arab Emirates: Recent Past, Current and Future
Analysis in US$ Million by Technology for the Period 2020-2027

Table 101: United Arab Emirates Biopharmaceutical Bioseparation
Systems Historic Market Analysis in US$ Million by Technology:
2012-2019

Table 102: Biopharmaceutical Bioseparation Systems Market Share
Distribution in United Arab Emirates by Technology: 2012 VS
2020 VS 2027

REST OF MIDDLE EAST
Table 103: Rest of Middle East Biopharmaceutical Bioseparation
Systems Latent Demand Forecasts in US$ Million by Technology:
2020-2027

Table 104: Biopharmaceutical Bioseparation Systems Market in
Rest of Middle East: A Historic Perspective by Technology in
US$ Million for the Period 2012-2019

Table 105: Rest of Middle East Biopharmaceutical Bioseparation
Systems Market Share Breakdown by Technology: 2012 VS 2020 VS
2027

AFRICA
Table 106: Biopharmaceutical Bioseparation Systems Market in
US$ Million in Africa by Technology: 2020-2027

Table 107: African Biopharmaceutical Bioseparation Systems
Market Retrospective Analysis in US$ Million by Technology:
2012-2019

Table 108: African Biopharmaceutical Bioseparation Systems
Market Share Breakdown by Technology: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 55
Read the full report: https://www.reportlinker.com/p03646060/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001